Bokus

John Geigert – författare

Visar alla böcker från författaren John Geigert. Handla med fri frakt och snabb leverans.

14 produkter

  1. John Geigert - Challenge of CMC Regulatory Compliance for Biopharmaceuticals, Inbunden. Tillgänglighet: Lägg i varukorg

    Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    Av John Geigert

    Inbunden, 2026

    2026 kr

    Lägg i varukorg

    CMC regulatory compliance strategy for biopharmaceuticals has become vastly more complex and challenging in the past couple of years, especially as the number of gene therapies have entered development and even market approval. Biopharmaceuticals today can be either protein-based or gene-based. For …

  2. John Geigert - Challenge of CMC Regulatory Compliance for Biopharmaceuticals, Inbunden. Tillgänglighet: Lägg i varukorg

    Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    Av John Geigert

    Inbunden, 2003

    2010 kr

    Lägg i varukorg

    "The greater our knowledge increases, the more our ignorance unfolds. " U. S. President John F. Kennedy, speech, Rice University, September 12, 1962 My primary purpose for writing this book was much more than to provide another information source on Chemistry, Manufacturing & Controls (CMC) that …

  3. John Geigert - Challenge of CMC Regulatory Compliance for Biopharmaceuticals, E-bok. Tillgänglighet: Lägg i varukorg

    Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    Av John Geigert

    E-bok, 2012

    2948 kr

    Lägg i varukorg

    "The greater our knowledge increases, the more our ignorance unfolds. " U. S. President John F. Kennedy, speech, Rice University, September 12, 1962 My primary purpose for writing this book was much more than to provide another information source on Chemistry, Manufacturing & Controls (CMC) that …

  4. John Geigert - Challenge of CMC Regulatory Compliance for Biopharmaceuticals, Häftad. Tillgänglighet: Lägg i varukorg

    Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    Av John Geigert

    Häftad, 2012

    2250 kr

    Lägg i varukorg

    "The greater our knowledge increases, the more our ignorance unfolds. " U. S. President John F. Kennedy, speech, Rice University, September 12, 1962 My primary purpose for writing this book was much more than to provide another information source on Chemistry, Manufacturing & Controls (CMC) that …

  5. John Geigert - Challenge of CMC Regulatory Compliance for Biopharmaceuticals, Inbunden. Tillgänglighet: Lägg i varukorg

    Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    Av John Geigert

    Inbunden, 2013

    2811 kr

    Lägg i varukorg

    This book highlights the challenges facing quality assurance/quality control (QA/QC) in today's biopharmaceutical environment and presents the strategic importance and value generated by QA/QC for their involvement in control of manufacturing. It will put into perspective the need for a graded …

  6. John Geigert - Challenge of CMC Regulatory Compliance for Biopharmaceuticals, E-bok. Tillgänglighet: Lägg i varukorg

    Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    Av John Geigert

    E-bok, 2014

    2599 kr

    Lägg i varukorg

    This book highlights the challenges facing quality assurance/quality control (QA/QC) in today''s biopharmaceutical environment and presents the strategic importance and value generated by QA/QC for their involvement in control of manufacturing. It will put into perspective the need for a graded …

  7. John Geigert - Challenge of CMC Regulatory Compliance for Biopharmaceuticals, Häftad. Tillgänglighet: Lägg i varukorg

    Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    Av John Geigert

    Häftad, 2016

    2026 kr

    Lägg i varukorg

    This book highlights the challenges facing quality assurance/quality control (QA/QC) in today's biopharmaceutical environment and presents the strategic importance and value generated by QA/QC for their involvement in control of manufacturing. It will put into perspective the need for a graded …

  8. John Geigert - Challenge of CMC Regulatory Compliance for Biopharmaceuticals, Inbunden. Tillgänglighet: Lägg i varukorg

    Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    Av John Geigert

    Inbunden, 2019

    1799 kr

    Lägg i varukorg

    Biopharmaceuticals (i.e., biological medicines sourced from genetically-engineered living systems) for treatment of human diseases have become a significant percentage of the pharmaceutical industry. And not just the recombinant DNA-derived proteins and monoclonal antibodies (both from the …

  9. John Geigert - Challenge of CMC Regulatory Compliance for Biopharmaceuticals, E-bok. Tillgänglighet: Lägg i varukorg

    Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    Av John Geigert

    E-bok, 2019

    2267 kr

    Lägg i varukorg

    Biopharmaceuticals (i.e., biological medicines sourced from genetically-engineered living systems) for treatment of human diseases have become a significant percentage of the pharmaceutical industry. And not just the recombinant DNA-derived proteins and monoclonal antibodies (both from the …

  10. John Geigert - Challenge of CMC Regulatory Compliance for Biopharmaceuticals, E-bok. Tillgänglighet: Lägg i varukorg

    Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    Av John Geigert

    E-bok, 2023

    2341 kr

    Lägg i varukorg

    Each year for the past three years, there have been about 50 new molecular medicines approved by the United States Food & Drug Administration (FDA), of which approximately 25% were new biopharmaceuticals. Over 200 recombinant proteins, monoclonal antibodies, antibody drug conjugates, fusion …

  11. John Geigert - Challenge of CMC Regulatory Compliance for Biopharmaceuticals, Häftad. Tillgänglighet: Lägg i varukorg

    Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    Av John Geigert

    Häftad, 2024

    1875 kr

    Lägg i varukorg

    Each year for the past three years, there have been about 50 new molecular medicines approved by the United States Food & Drug Administration (FDA), of which approximately 25% were new biopharmaceuticals. Over 200 recombinant proteins, monoclonal antibodies, antibody drug conjugates, fusion …

  12. John Geigert - Challenge of CMC Regulatory Compliance for Biopharmaceuticals, E-bok. Tillgänglighet: Lägg i varukorg

    Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    Av John Geigert

    E-bok, 2026

    2110 kr

    Lägg i varukorg

    CMC regulatory compliance strategy for biopharmaceuticals has become vastly more complex and challenging in the past couple of years, especially as the number of gene therapies have entered development and even market approval. Biopharmaceuticals today can be either protein-based or gene-based. For …

  13. John Geigert - Challenge of CMC Regulatory Compliance for Biopharmaceuticals, Inbunden. Tillgänglighet: Tillfälligt slut

    Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    Av John Geigert

    Inbunden, 2023

    2478 kr

    Tillfälligt slut

    Each year for the past three years, there have been about 50 new molecular medicines approved by the United States Food & Drug Administration (FDA), of which approximately 25% were new biopharmaceuticals. Over 200 recombinant proteins, monoclonal antibodies, antibody drug conjugates, fusion …

  14. John Geigert - The Challenge of CMC Regulatory Compliance for Biopharmaceuticals. Tillgänglighet: Tillfälligt slut

    The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

    Av John Geigert

    2023

    686 kr

    Tillfälligt slut